Patient Blog
Real stories, tips, and insights from patients living with hypoparathyroidism. You are not alone on this journey.
AACE 2026: Early Lessons in Implementing Yorvipath (Palopegteriparatide) Therapy
A case series from AACE 2026 highlights that Yorvipath isn't one-size-fits-all — some patients discontinued all supplements, others developed early hypercalcemia. Close monitoring and individualized dosing are key.
The 500 mg Calcium Myth: What HP Patients Actually Need to Know
There's a common misconception that the body can only absorb 500 mg of calcium at a time, and that anything over 500 mg harms the kidneys. Let's walk through the physiology — because this causes a lot of unnecessary anxiety, especially for HP patients who often need higher doses.
Calcium Intake on Yorvipath: What You Need to Know
On conventional therapy, many of us need several grams of Ca a day to stay stable. But as patients transition to Yorvipath, food calcium becomes critically important — and many patients have no idea how much they are eating.
Have a Story to Share?
Your experience with hypoparathyroidism matters. Submit a blog post and help others feel less alone on their journey.